- Home
- UXIN vs ORIC Comparison
UXIN vs ORIC Comparison
Compare UXIN & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UXIN
- ORIC
- Stock Information
- Founded
- UXIN 2011
- ORIC 2014
- Country
- UXIN China
- ORIC United States
- Employees
- UXIN N/A
- ORIC N/A
- Industry
- UXIN Business Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- UXIN Consumer Discretionary
- ORIC Health Care
- Exchange
- UXIN Nasdaq
- ORIC Nasdaq
- Market Cap
- UXIN 789.6M
- ORIC 940.8M
- IPO Year
- UXIN 2018
- ORIC 2020
- Fundamental
- Price
- UXIN $3.80
- ORIC $9.59
- Analyst Decision
- UXIN
- ORIC Strong Buy
- Analyst Count
- UXIN 0
- ORIC 9
- Target Price
- UXIN N/A
- ORIC $18.29
- AVG Volume (30 Days)
- UXIN 139.3K
- ORIC 1.2M
- Earning Date
- UXIN 09-22-2025
- ORIC 08-19-2025
- Dividend Yield
- UXIN N/A
- ORIC N/A
- EPS Growth
- UXIN N/A
- ORIC N/A
- EPS
- UXIN 0.94
- ORIC N/A
- Revenue
- UXIN $300,239,165.00
- ORIC N/A
- Revenue This Year
- UXIN N/A
- ORIC N/A
- Revenue Next Year
- UXIN N/A
- ORIC N/A
- P/E Ratio
- UXIN $3.96
- ORIC N/A
- Revenue Growth
- UXIN 58.48
- ORIC N/A
- 52 Week Low
- UXIN $1.41
- ORIC $3.90
- 52 Week High
- UXIN $7.84
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- UXIN 43.85
- ORIC 43.55
- Support Level
- UXIN $3.32
- ORIC $9.63
- Resistance Level
- UXIN $4.13
- ORIC $10.31
- Average True Range (ATR)
- UXIN 0.33
- ORIC 0.64
- MACD
- UXIN -0.08
- ORIC -0.27
- Stochastic Oscillator
- UXIN 30.46
- ORIC 17.96
About UXIN Uxin Limited ADS
Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.